Cargando…
Poly-N-Acetyllactosamine Neo-Glycoproteins as Nanomolar Ligands of Human Galectin-3: Binding Kinetics and Modeling
Galectin-3 (Gal-3) is recognized as a prognostic marker in several cancer types. Its involvement in tumor development and proliferation makes this lectin a promising target for early cancer diagnosis and anti-cancer therapies. Gal-3 recognizes poly-N-acetyllactosamine (LacNAc)-based carbohydrate mot...
Autores principales: | Bumba, Ladislav, Laaf, Dominic, Spiwok, Vojtěch, Elling, Lothar, Křen, Vladimír, Bojarová, Pavla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5855594/ https://www.ncbi.nlm.nih.gov/pubmed/29373511 http://dx.doi.org/10.3390/ijms19020372 |
Ejemplares similares
-
Galectin Binding to Neo-Glycoproteins: LacDiNAc Conjugated BSA as Ligand for Human Galectin-3
por: Böcker, Sophia, et al.
Publicado: (2015) -
Enzymatic Synthesis of N-Acetyllactosamine (LacNAc) Type 1 Oligomers and Characterization as Multivalent Galectin Ligands
por: Fischöder, Thomas, et al.
Publicado: (2017) -
Biocompatible glyconanomaterials based on HPMA-copolymer for specific targeting of galectin-3
por: Bojarová, P., et al.
Publicado: (2018) -
Biotinylated N-Acetyllactosamine- and N,N-Diacetyllactosamine-Based Oligosaccharides as Novel Ligands for Human Galectin-3 †
por: Böcker, Sophia, et al.
Publicado: (2017) -
Chemo-enzymatic modification of poly-N-acetyllactosamine (LacNAc) oligomers and N,N-diacetyllactosamine (LacDiNAc) based on galactose oxidase treatment
por: Kupper, Christiane E, et al.
Publicado: (2012)